Lipum AB (Sweden) Insiders
| LIPUM Stock | SEK 18.00 2.80 13.46% |
Lipum AB employs about 5 people. The company is managed by 5 executives with a total tenure of roughly 12 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Breaking down Lipum AB's management performance can provide insight into the firm performance.
| Pernilla Abrahamsson Insider Chief Officer |
| Associate Lindquist Insider CoFounder Research |
Lipum |
Lipum AB Management Team Effectiveness
The company has return on total asset (ROA) of (0.9118) % which means that it has lost $0.9118 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.8072) %, meaning that it generated substantial loss on money invested by shareholders. Lipum AB's management efficiency ratios could be used to measure how well Lipum AB manages its routine affairs as well as how well it operates its assets and liabilities.Lipum AB Workforce Comparison
Lipum AB is rated fifth overall in number of employees category among its peers. The total workforce of Biotechnology industry is now estimated at about 86.0. Lipum AB holds roughly 5.0 in number of employees claiming about 6% of stocks in Biotechnology industry.
Lipum AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Lipum AB Price Series Summation is a cross summation of Lipum AB price series and its benchmark/peer.
Lipum AB Notable Stakeholders
A Lipum AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Lipum AB often face trade-offs trying to please all of them. Lipum AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Lipum AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Pernilla Abrahamsson | Chief Officer | Profile | |
| Associate Lindquist | CoFounder Research | Profile | |
| Pr Hernell | CoFounder Director | Profile | |
| Marina Norberg | Chief Officer | Profile | |
| Einar Ponten | Chief Officer | Profile |
About Lipum AB Management Performance
The success or failure of an entity such as Lipum AB often depends on how effective the management is. Lipum AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Lipum management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Lipum management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Lipum AB , a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. The company was founded in 2010 and is headquartered in Ume, Sweden. Lipum AB is traded on Stockholm Stock Exchange in Sweden.
Please note, the imprecision that can be found in Lipum AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Lipum AB. Check Lipum AB's Beneish M Score to see the likelihood of Lipum AB's management manipulating its earnings.
Lipum AB Workforce Analysis
Traditionally, organizations such as Lipum AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Lipum AB within its industry.Lipum AB Manpower Efficiency
Return on Lipum AB Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 10.5M | |
| Net Loss Per Executive | 10.5M |
Additional Tools for Lipum Stock Analysis
When running Lipum AB's price analysis, check to measure Lipum AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipum AB is operating at the current time. Most of Lipum AB's value examination focuses on studying past and present price action to predict the probability of Lipum AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipum AB's price. Additionally, you may evaluate how the addition of Lipum AB to your portfolios can decrease your overall portfolio volatility.